247 related articles for article (PubMed ID: 28081671)
41. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
[TBL] [Abstract][Full Text] [Related]
42. Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.
Greenwood BM; Aseffa A; Caugant DA; Diallo K; Kristiansen PA; Maiden MCJ; Stuart JM; Trotter CL
Trop Med Int Health; 2019 Feb; 24(2):143-154. PubMed ID: 30461138
[TBL] [Abstract][Full Text] [Related]
43. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
[TBL] [Abstract][Full Text] [Related]
45. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
[TBL] [Abstract][Full Text] [Related]
46. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
47. A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa.
Sambo L; Chan M; Davis S; Lake A; Berkley S; Poonawalla C; Elias CJ
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S387-8. PubMed ID: 26553663
[No Abstract] [Full Text] [Related]
48. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.
Retchless AC; Hu F; Ouédraogo AS; Diarra S; Knipe K; Sheth M; Rowe LA; Sangaré L; Ky Ba A; Ouangraoua S; Batra D; Novak RT; Ouédraogo Traoré R; Wang X
mSphere; 2016; 1(6):. PubMed ID: 27904879
[TBL] [Abstract][Full Text] [Related]
49. Impact of vaccination on meningococcal epidemiology.
Stefanelli P; Rezza G
Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
[TBL] [Abstract][Full Text] [Related]
50. Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.
Guerin PJ; Naess LM; Fogg C; Rosenqvist E; Pinoges L; Bajunirwe F; Nabasumba C; Borrow R; Frøholm LO; Ghabri S; Batwala V; Twesigye R; Aaberge IS; Røttingen JA; Piola P; Caugant DA
PLoS Negl Trop Dis; 2008; 2(12):e342. PubMed ID: 19048025
[TBL] [Abstract][Full Text] [Related]
51. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.
Tartof S; Cohn A; Tarbangdo F; Djingarey MH; Messonnier N; Clark TA; Kambou JL; Novak R; Diomandé FV; Medah I; Jackson ML
PLoS One; 2013; 8(5):e63605. PubMed ID: 23671685
[TBL] [Abstract][Full Text] [Related]
52. Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative.
Borrow R; Caugant DA; Ceyhan M; Christensen H; Dinleyici EC; Findlow J; Glennie L; Von Gottberg A; Kechrid A; Vázquez Moreno J; Razki A; Smith V; Taha MK; Tali-Maamar H; Zerouali K;
J Infect; 2017 Jul; 75(1):1-11. PubMed ID: 28455205
[TBL] [Abstract][Full Text] [Related]
53. Lessons from the Meningitis Vaccine Project.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Viral Immunol; 2018 Mar; 31(2):109-113. PubMed ID: 29116892
[TBL] [Abstract][Full Text] [Related]
54. Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.
Cibrelus L; Medah I; Koussoubé D; Yélbeogo D; Fernandez K; Lingani C; Djingarey M; Hugonnet S
Emerg Infect Dis; 2015 Nov; 21(11):2063-6. PubMed ID: 26488128
[TBL] [Abstract][Full Text] [Related]
55. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
56. Gauging the epidemic potential of a widely circulating non-invasive meningococcal strain in Africa.
Brynildsrud OB; Eldholm V; Rakhimova A; Kristiansen PA; Caugant DA
Microb Genom; 2019 Aug; 5(8):. PubMed ID: 31454306
[No Abstract] [Full Text] [Related]
57. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
[TBL] [Abstract][Full Text] [Related]
58. Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies.
Sherman AC; Stephens DS
Expert Rev Vaccines; 2020 May; 19(5):455-463. PubMed ID: 32321332
[TBL] [Abstract][Full Text] [Related]
59. Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
Diallo AO; Soeters HM; Yameogo I; Sawadogo G; Aké F; Lingani C; Wang X; Bita A; Fall A; Sangaré L; Ouédraogo-Traoré R; Medah I; Bicaba B; Novak RT;
PLoS One; 2017; 12(11):e0187466. PubMed ID: 29095907
[TBL] [Abstract][Full Text] [Related]
60. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
